Adial Pharmaceuticals Targets $40B Addiction Market
Adial Pharmaceuticals acquires patent for genetic diagnostic tool to identify patients who may respond well to their lead drug AD04, ...
- Latest
- Trending
Adial Pharmaceuticals acquires patent for genetic diagnostic tool to identify patients who may respond well to their lead drug AD04, ...
Chinese space startups are racing to catch up with SpaceX by reducing costs and developing reusable rockets. Private companies aim ...
Amazon is offering skills training programs to help students secure well-paying jobs in the future. AI skills are becoming essential, ...
Sosei Group Corporation announces operational activities and consolidated results, including significant investment, marketing approval, and partnerships. Despite revenue decrease, the ...
The Biden-Harris Administration is investing $5 billion in semiconductor research and development to strengthen domestic manufacturing and boost innovation. This ...
Life Science REIT has fully let Building 5 at Oxford Technology Park to WAE Technologies. The move highlights the demand ...
Regeneron Pharmaceuticals, a leading biopharmaceutical company, is gaining recognition for its innovative approach and strong financial performance. With a diverse ...
ODDITY Tech Ltd. (NASDAQ: ODD) has announced the release date of its Q4 and full year 2023 financial results. The ...
Mirion Technologies executives are set to present at the Citi Global Industrial Tech and Mobility Conference. The webcast will provide ...
Beamr Imaging, a video optimization technology company, plans to raise $12 million through a public offering. The funds will support ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.